Immunocore develops biological product candidates based on its ImmTAX platform, from Oxfordshire, United Kingdom. IMCR reports earnings on Thu, Nov 5, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Aug 21 | JP Morgan | Reinstated | Buy | |
| Aug 3 | Mizuho | Maintained | Hold | |
| Mar 16 | Jefferies | Downgrade | Hold |
Seasonality
How IMCR has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.
Whale Options Flow
90DNo whale options trades in IMCR in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether IMCR is in one of them and how their past IMCR trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered IMCR in an article yet. Here's the latest on the wider market.
About Immunocore Holdings
Immunocore is a biological products company based in Oxfordshire, United Kingdom. It develops product candidates built on its ImmTAX platform, which it relies on as its core proprietary know-how. Its work involves collaborations with corporate partners, outside scientific collaborators and contract research organizations. Most of its product candidates are still in development and not yet sold to customers.
- Headquarters
- Oxfordshire, United Kingdom